July 1 (Bloomberg) -- Bayer AG’s health-care unit filed a lawsuit to prevent Teva Pharmaceutical Industries Ltd. from selling a copy of the erectile dysfunction pill Levitra. Teva is seeking U.S. Food and Drug Administration approval to sell a generic version of the drug. Leverkusen, Germany-based Bayer Schering Pharma is seeking a court order to prevent the FDA approval until a patent expires in 2018.
Entradas
No hay comentarios:
Publicar un comentario